1.
Blauvelt A, Lacour J-P, Toth D, Laquer V, Beissert S, Wollenberg A, Herranz P, Pink A, Peris K, Fangel S, Saeki H. Long-Term Improvements Observed in Tralokinumab-Treated Patients with Moderate-to-Severe Atopic Dermatitis: an ECZTEND Interim Analysis. J of Skin [Internet]. 2021Nov.5 [cited 2022Jul.7];5(6):s59. Available from: https://www.jofskin.org/index.php/skin/article/view/1410